Treatment of Acute Ischemic STroke With Edaravone Dexborneol II
Status:
Not yet recruiting
Trial end date:
2024-04-30
Target enrollment:
Participant gender:
Summary
This study is a multicentre, randomized, double-blind, placebo parallel controlled,
investigator-sponsored study that aims to investigate the efficacy and safety of Edaravone
Dexborneol treatment in patients with acute ischemic stroke who had received early
reperfusion therapy.